Analytical Data
-
Gene name
idnk
- Application
-
Alternative Names
IDNK;C9orf103;Probable gluconokinase
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P39208
-
Expression Region
1-187aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMAGESFI LMGVSGSGKT LIGSKVAALL SAKFIDGDDL HPAKNIDKMS QGIPLSDEDR LPWLERLNDA SYSLYKKNET GFIVCSSLKK QYRDILRKGS PHVHFLWLDG DYETILARMQ RRAGHFMPVA LLKSQFEALE RPQADEQDIV RIDINHDIAN VTEQCRQAVL AIRQNRICAK EGSASDQRCE
-
Molecular Weight
23 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IDNK (Inhibitor of DNA Damage Kinase) is an emerging protein that has garnered significant interest in the field of molecular biology and cancer research due to its potential role in cellular response to DNA damage and repair mechanisms. Research indicates that IDNK may play a crucial role in regulating key pathways associated with DNA damage response (DDR), which is essential for maintaining genomic stability. The dysregulation of this protein could contribute to tumorigenesis and cancer progression, making it a potential target for therapeutic intervention. Studies have begun to explore the structural characteristics of IDNK, its interaction with other proteins involved in the DDR network, and its implication in various cancer types. Furthermore, understanding the molecular mechanisms underlying IDNK's function may provide insights into developing novel strategies for cancer treatment, particularly in tumors exhibiting resistance to conventional therapies. As researchers delve deeper into the biological functions and regulatory mechanisms of IDNK, the hope is that these findings will contribute to the advancement of precision medicine approaches in oncology.
